| Jiang, Wei |
NCT06492460: 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 3 | 422 | RoW | Drugļ¼Cisplatin, CDDP Drug | Sun Yat-sen University, Hunan Cancer Hospital, Guilin Medical University, China, Jiangsu Cancer Institute & Hospital, Xiangya Hospital of Central South University | Squamous Cell Carcinoma of Head and Neck | 09/29 | 07/33 | | |
NCT05527470: Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma |
|
|
| Recruiting | 3 | 440 | RoW | Gemcitabine,Cisplatin, Induction chemotherapy regimen, Intensity-modulated radiation therapy (IMRT), Cisplatin, Concurrent chemotherapy regimen | Wei Jiang, Wuzhou Red Cross Hospital, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Lingshan people's Hospital, Laibin People's Hospital, Nationalities Hospital of Guangxi Zhuang Autonomous Region | Nasopharyngeal Carcinoma | 11/25 | 11/27 | | |
NCT04515602: Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) |
|
|
| Not yet recruiting | 3 | 410 | RoW | Primary debulking surgery, PDS, Neoadjuvant chemotherapy, Neoadjuvant chemotherapy followed by interval debulking surgery, NACT-IDS, PARPi | Shanghai Gynecologic Oncology Group, Obstetrics & Gynecology Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai First Maternity and Infant Hospital | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | 01/28 | 01/28 | | |
| Recruiting | 2 | 30 | RoW | Niraparib | Tianjin Huanhu Hospital | Recurrent Glioblastoma | 01/22 | 01/23 | | |
NCT04600817: A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT) |
|
|
| Active, not recruiting | 2 | 160 | RoW | TJ107, TJ107 placebo | TJ Biopharma Co., Ltd. | Newly Diagnosed Glioblastoma | 12/24 | 12/24 | | |
NCT05068427: Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC. |
|
|
| Completed | 2 | 34 | RoW | Chidamide, CS055, Envafolimab, KN035 | Chipscreen Biosciences, Ltd. | Non Small Cell Lung Cancer | 02/23 | 05/24 | | |
| Recruiting | 2 | 200 | RoW | Camrelizumab, PD-1 antibody, Gemcitabine, Gem, Induction Cisplatin, DDP, intensity-modulated radiotherapy, IMRT, Concurrent cisplatin | Wei Jiang, Wuzhou Red Cross Hospital, Guangxi Nanxishan Hospital, Laibin People's Hospital, Lingshan people's Hospital | Nasopharyngeal Carcinoma | 04/25 | 04/26 | | |
| Recruiting | 2 | 167 | RoW | Surgery, secondary cytoreduction, carboplatin/taxane, carboplatin/gemcitabine, cisplatin/gemcitabine, liposome doxorubicin/carboplatin..., third-line therapy, Niraparib, maintenance therapy | Shanghai Gynecologic Oncology Group, Fudan University, Shanghai Jiao Tong University School of Medicine, Zhejiang Cancer Hospital, Sun Yat-sen University | Ovarian Cancer Recurrent, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | 06/25 | 12/26 | | |
NCT06536400: Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation |
|
|
| Recruiting | 1 | 316 | RoW | HSK42360 | Haisco Pharmaceutical Group Co., Ltd. | Solid Tumors | 08/26 | 07/27 | | |
NCT03131427: China Registry for Genetic / Metabolic Liver Diseases |
|
|
| Recruiting | N/A | 20000 | RoW | Standard of care | Beijing Friendship Hospital, Beijing YouAn Hospital, Henan Provincial People's Hospital, Beijing Ditan Hospital, Hebei Medical University Third Hospital, Peking University First Hospital, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Nanfang Hospital of Southern Medical University, Logistics University of Chinese People's Armed Police Forces, Beijing Anzhen Hospital, West China Second University Hospital of Sichuan University, Jinshan Hospital Fudan University, Fudan University | Genetic/Metabolic Liver Diseases | 04/22 | 04/27 | | |
BESMILE-HF, NCT03180320: Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure ( Study) |
|
|
| Recruiting | N/A | 150 | RoW | BESMILE-HF program, Usual medications | Guangdong Provincial Hospital of Traditional Chinese Medicine | Heart Failure NYHA Class II, Heart Failure NYHA Class III | 12/22 | 12/22 | | |
NCT05176821: Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection |
|
|
| Recruiting | N/A | 186 | RoW | esomeprazole plus amoxicillin, HDDT, amoxicillin, furazolidone, bismuth potassium citrate , esomeprazole, FT | Shanghai Zhongshan Hospital | H. Pylori Infection | 12/22 | 12/22 | | |
GIANT, NCT04765592: Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System ( Study) |
|
|
| Active, not recruiting | N/A | 88 | RoW | WeFlow-Arch Modeler Embedded Branch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 02/25 | 02/29 | | |
NCT06327126: Efficacy and Safety of Single-session Endoscopic Stone Extraction |
|
|
| Completed | N/A | 563 | RoW | two-session ERCP, single-session ERCP | Beijing Friendship Hospital | Choledocholithiasis With Acute Cholangitis | 05/24 | 07/24 | | |
NCT06349954: Effectiveness and Safety of Single-session Endoscopic Stone Extraction |
|
|
| Recruiting | N/A | 64 | RoW | single-session ERCP, two-session ERCP | Beijing Friendship Hospital | Choledocholithiasis With Acute Cholangitis | 12/24 | 12/24 | | |
| Recruiting | N/A | 240 | RoW | Carvedilol 12.5 MG, Nucleos(t)ide Analogues | Beijing Friendship Hospital | Liver Cirrhosis, Portal Hypertension | 10/24 | 10/24 | | |
| Chen, Lei |
| Completed | 3 | 1281 | Europe, Canada, Japan, US, RoW | Mirikizumab, LY3074828, Placebo | Eli Lilly and Company | Ulcerative Colitis | 01/21 | 05/24 | | |
|
|
|
|
| Completed | 3 | 1177 | Europe, Canada, Japan, US, RoW | Mirikizumab SC, LY3074828, Mirikizumab IV, Placebo SC | Eli Lilly and Company | Ulcerative Colitis | 11/21 | 12/24 | | |
|
|
TQB2450-III-08, NCT04809142: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer |
|
|
| Recruiting | 3 | 392 | RoW | TQB2450 Injection, Anlotinib hydrochloride, Oxaliplatin injection, Capecitabine tablets, Gemcitabine hydrochloride injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Biliary Cancer | 03/22 | 02/23 | | |
NCT05862337: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. |
|
|
| Recruiting | 3 | 480 | RoW | Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hepatocellular Carcinoma | 08/24 | 12/26 | | |
NCT06492460: 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 3 | 422 | RoW | Drugļ¼Cisplatin, CDDP Drug | Sun Yat-sen University, Hunan Cancer Hospital, Guilin Medical University, China, Jiangsu Cancer Institute & Hospital, Xiangya Hospital of Central South University | Squamous Cell Carcinoma of Head and Neck | 09/29 | 07/33 | | |
NCT06738979: A Clinical Study Comparing Semaglutide Injection and WegovyĀ® for Weight Management in Obese Subjects |
|
|
| Not yet recruiting | 3 | 408 | RoW | TQF3510 (Semaglutide Injection), WegovyĀ® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Obesity | 07/26 | 08/26 | | |
| Recruiting | 3 | 248 | RoW | pimavanserin tartrate, placebo | Tasly Pharmaceutical Group Co., Ltd | Parkinson's Disease Psychosis | 06/25 | 01/26 | | |
| Recruiting | 3 | 1063 | Europe, Canada, Japan, US, RoW | Mirikizumab, LY3074828 | Eli Lilly and Company | Ulcerative Colitis | 07/26 | 12/27 | | |
|
NCT03977480: Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis |
|
|
| Terminated | 2 | 70 | RoW | Hemay007, Placebo | Tianjin Hemay Pharmaceutical Co., Ltd | Ulcerative Colitis | 08/22 | 08/22 | | |
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | 2 | 318 | RoW | HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Type 2 Diabetes | 04/25 | 04/25 | | |
NCT06493747: Acupuncture + Neuromodulation for Post-Stroke Aphasia |
|
|
| Recruiting | N/A | 82 | RoW | Combined Low- and High-Frequency rTMS Intervention, Combined High- and Low-Frequency rTMS Intervention, rTMS, rTMS + Acupuncture, Control Group, Acupuncture | Shanghai Yueyang Integrated Medicine Hospital | Aphasia, Rehabilitation | 10/24 | 01/25 | | |
| Not yet recruiting | N/A | 220 | RoW | Generative AI Based Puncture Surgery Navigation System, Cone beam CT | Wuhan Union Hospital, China | Lung Nodules | 05/25 | 05/25 | | |
| Ji, Xunming |
NCT05965687: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3) |
|
|
| Recruiting | 3 | 1230 | RoW | Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA) | Ji Xunming,MD,PhD, Beijing Friendship Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Tongren Hospital, People's Hospital of Beijing Daxing District, Tianjin Huanhu Hospital, Guizhou Provincial People's Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Jining First People's Hospital, Linyi People's Hospital, Nanyang Central Hospital, Rizhao People's Hospital, Zhumadian Central Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, The Second Hospital of Anhui Medical University, Changsha Central Hospital, Jiujiang University Affiliated Hospital, Liaocheng People's Hospital, Chengde Central Hospital, The First Affiliated Hospital of Anhui Medical University, Jiangxi Provincial People's Hopital | Acute Ischemic Stroke | 08/24 | 10/24 | | |
RECAST-MT, NCT06559241: Remote Ischemic Conditioning for Acute Ischemic Stroke Treated with Mechanical Thrombectomyļ¼ļ¼ |
|
|
| Recruiting | 3 | 2105 | RoW | 14-day remote ischemic conditioning, 14-day RIC, 30-day remote ischemic conditioning, 30-day RIC, Endovascular thrombectomy, EVT, Best medical management | Capital Medical University | Acute Ischemic Stroke, Anterior Circulation Brain Infarction | 11/26 | 02/27 | | |
NCT05965193: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Strokeļ¼Longterm Outcome (OPENS-3L) |
|
|
| Recruiting | 3 | 1230 | RoW | Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA) | Ji Xunming,MD,PhD, Beijing Friendship Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Tongren Hospital, People's Hospital of Beijing Daxing District, Tianjin Huanhu Hospital, Guizhou Provincial People's Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Jining First People's Hospital, Linyi People's Hospital, Nanyang Central Hospital, Rizhao People's Hospital, Zhumadian Central Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, The Second Hospital of Anhui Medical University, Changsha Central Hospital | Acute Ischemic Stroke | 08/25 | 10/25 | | |
| Recruiting | 2/3 | 98 | RoW | Statin | Capital Medical University | Intracerebral Hemorrhage, Statins | 06/24 | 11/24 | | |
IRIS, NCT06238024: Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment |
|
|
| Completed | 2/3 | 108 | RoW | Tocilizumab, NaCl 0.9% 100ml | Suzhou Municipal Hospital of Anhui Province, Xuanwu Hospital, Beijing | Interleukin-6, Ischemic Stroke, Endovascular Treatment | 06/24 | 09/24 | | |
| Recruiting | 2 | 100 | RoW | NBO | Capital Medical University | Acute Stroke, Ischemic Stroke, Acute | 07/22 | 10/22 | | |
| Completed | 2 | 282 | RoW | Normobaric Hyperoxia, NBO, Sham Normobaric Hyperoxia, Sham NBO, Endovascular Thrombectomy, EVT | Capital Medical University, Tianjin Huanhu Hospital, Shengli Oilfield Hospital, Beijing Fengtai You'anmen Hospital, Jiujiang University Affiliated Hospital, Zhangzhou Municipal Hospital of Fujian Province, Baotou Central Hospital, Luoyang Central Hospital, Nanyang Central Hospital, Qingdao Central Hospital, The Third People's Hospital of Jinan, Rizhao People's Hospital, Anyang People's Hospital, Shanghai 10th People's Hospital, Dalian Municipal Central Hospital, Zhoukou Central Hospital, Nanshi Hospital of Nanyang, The second Nanning People's Hospital, Zhumadian Central Hospital, Taizhou Hospital, Second Affiliated Hospital of Nanchang University | Stroke, Acute, Neuroprotection | 05/23 | 05/23 | | |
| Recruiting | 1 | 32 | RoW | chlorpromazine and promethazine, C+P, lytic cocktail, Placebo group, Control group, endovascular thrombectomy, rt-PA, Intravenous thrombolysis | Capital Medical University, Linyi People's Hospital | Acute Ischemic Stroke | 01/25 | 02/25 | | |
RE-HIBER, NCT04554797: Regional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 60 | RoW | Regional Hypothermia | Capital Medical University | Stroke, Neuroprotection, Hypothermia | 12/20 | 03/21 | | |
RIC-PMD, NCT03546309: Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy |
|
|
| Recruiting | N/A | 42 | RoW | RIC group, Medication group | Capital Medical University, The Fifth Medical Center of the Chinese People's Liberation Army (PLA) General Hospital | Moyamoya Disease, Pediatric | 12/24 | 02/25 | | |
| Not yet recruiting | N/A | 40 | NA | remote ischemic conditioning | Capital Medical University | 2,3-Bisphosphoglycerate | 03/21 | 03/21 | | |
NCT02737189: Basilar Artery Occlusion Chinese Endovascular Trial |
|
|
| Completed | N/A | 217 | RoW | Mechanical embolectomy, Medical Treatment | Xuanwu Hospital, Beijing, Zhangzhou Municipal Hospital of Fujian Province, The First People's Hospital of Changzhou, Xinqiao Hospital of Chongqing, Changhai Hospital, Baotou Central Hospital, The 904 Hospital of PLA, Linyi People's Hospital, The 985 Hospital of PLA, Taiyuan, Shanxi, The First Affiliated Hospital with Nanjing Medical University, Tianjin TEDA Hospital, Liaocheng People's Hospital, Luoyang Central Hospital, Subei People's Hospital of Jiangsu Province, PLA 148 Hospital, Zibo, Shandong, Hebei General Hospital, Shengli Oilfield Hospital, Shenzhen Bao'an District People's Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Peking University Binhai Hospital, Beijing Tiantan Hospital, The Military General Hospital of Beijing, PLA, The First Affiliated Hospital of Shanxi Medical University, Beijing Luhe Hospital, Affiliated Hospital of Nantong University, The Affiliated Hospital Of Guizhou Medical University, Nanning Second People's Hospital, Chongqing Three Gorges Central Hospital, The First Affiliated Hospital of Dalian Medical University, The Fifth Central Hospital of Tianjinļ¼TianJin, Yantaishan Hospital, Nanyang Central Hospital, Second Affiliated Hospital of Soochow University, Tianjin Huanhu Hospital, The Affiliated Hospital of Northwest University, Xi'an NO.3 Hospital | Basilar Artery Occlusion, Ischemic Stroke, Cerebrovascular Disorders | 09/21 | 06/22 | | |
| Recruiting | N/A | 60 | RoW | Automatic ischemic conditioning treatment instrument, Regular treatment | Capital Medical University | Cerebral Small Vessel Diseases | 12/21 | 12/21 | | |
NCT05207475: Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA) |
|
|
| Recruiting | N/A | 30 | RoW | Remote ischemic conditioning | Capital Medical University | Cerebral Amyloid Angiopathy | 01/22 | 01/22 | | |
RIC-CAAH, NCT04757597: Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage |
|
|
| Recruiting | N/A | 30 | RoW | Remote ischemic conditioning | Capital Medical University, Wangjing Hospital, China Academy of Chinese Medical Sciences, Bejing Fengtai You'anmen Hospital | Intracerebral Hemorrhage Lobar, Cerebral Amyloid Angiopathy | 03/22 | 06/22 | | |
NCT04470492: Study on Prevention and Treatment of Atherosclerotic Cerebral Occlusive Disease With Remote Ischemic Conditioning |
|
|
| Not yet recruiting | N/A | 700 | NA | DoctormateĀ®+Medical Management, Medical Management | Ji Xunming,MD,PhD | Cerebral Atherosclerosis | 08/22 | 12/22 | | |
NCT05291585: The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis. |
|
|
| Completed | N/A | 60 | RoW | the dedicated venous sinus thrombectomy stent, balloon catheter thrombectomy | Ji Xunming,MD,PhD | Cerebral Venous Sinus Thrombosis | 03/23 | 07/23 | | |
NCT05263531: Remote Ischemic Conditioning for Motor Recovery After Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 20 | RoW | remote ischemic conditioning | Ji Xunming,MD,PhD | Ischemic Stroke | 12/22 | 01/23 | | |
NCT05426707: Remote Ischemic Conditioning for the Treatment of Resistant Hypertension |
|
|
| Not yet recruiting | N/A | 40 | NA | RIC, Sham-RIC | Ji Xunming,MD,PhD | Resistant Hypertension | 02/23 | 03/23 | | |
| Recruiting | N/A | 1000 | RoW | the level of biomarker in bood | Ji Xunming,MD,PhD | Ischemic Stroke | 03/23 | 12/25 | | |
NCT05448248: Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH) |
|
|
| Completed | N/A | 3276 | RoW | | Capital Medical University, Brain Hospital of Hunan Provincial, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Guizhou Provincial People's Hospital | Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis | 12/23 | 12/23 | | |
NCT05342714: Remote Ischemic Conditioning for Chronic Cerebral Artery Occlusion |
|
|
| Recruiting | N/A | 30 | RoW | Remote ischemic conditioning | Capital Medical University | Cerebral Artery Occlusion | 03/23 | 03/23 | | |
NCT05733338: The Effects of Intermittent Hypoxia on Acute Hypoxic Injury |
|
|
| Recruiting | N/A | 100 | RoW | Intermittent Hypoxia, Sham Intermittent Hypoxia | Capital Medical University | Acute Mountain Sickness | 04/23 | 04/23 | | |
NCT05760950: A Cohort Study of Patients With Intracranial Hemorrhage |
|
|
| Recruiting | N/A | 300 | RoW | Routine clinical treatment | Capital Medical University | Intracerebral Hemorrhage | 05/23 | 06/23 | | |
NCT05413837: Anatomical Variation of Cerebral Venous Sinus in Healthy Individuals |
|
|
| Recruiting | N/A | 40 | RoW | anotomy and variation of venous sinus, the level of biomarker in bood | Capital Medical University | Venous Sinus Thrombosis, Cranial | 08/23 | 08/23 | | |
NCT05128422: Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke |
|
|
| Completed | N/A | 120 | RoW | Normobaric oxygen therapy | Capital Medical University | Stroke, Endovascular Treatment, Neuroprotection | 10/23 | 10/23 | | |
| Not yet recruiting | N/A | 136 | RoW | Remote ischemic conditioning (RIC), Sham remote ischemic conditioning (Sham-RIC) | Ji Xunming,MD,PhD | Acute Ischemic Stroke | 12/23 | 12/23 | | |
NCT05820165: Brain Imaging in Cerebral Venous Outflow Disturbance |
|
|
| Recruiting | N/A | 80 | RoW | high-resolution 3D-T1, diffusion tensor imaging (DTI), resting-state functional magnetic resonance imaging (rs-fMRI), arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI), susceptibility-weighted images (SWIs) | Capital Medical University | Abnormal Cerebral Venous Sinus Morphology, Internal Jugular Vein Stenosis, Image | 12/23 | 12/24 | | |
NCT06584318: Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer |
|
|
| Recruiting | N/A | 20 | RoW | Intermittent hypoxia intervention | Capital Medical University | Colorectal Cancer | 03/25 | 04/25 | | |
NBOL, NCT05039697: Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onsetļ¼Longterm Outcome |
|
|
| Recruiting | N/A | 280 | RoW | oxygen | Capital Medical University | Stroke, Acute, Hypoxia-Ischemia, Brain, ENDOVASCULAR TREATMENT | 04/24 | 04/24 | | |
| Recruiting | N/A | 309 | RoW | Mechanical thrombectomy | Capital Medical University | Acute Ischemic Stroke, Basilar Artery Occlusion | 06/26 | 06/26 | | |
NCT05781880: Normobaric Hyperoxia Stabilizing Ischemic Penumbra |
|
|
| Recruiting | N/A | 78 | RoW | Oxygen 100%, Normobaric hyperoxia | Ji Xunming,MD,PhD | Acute Ischemic Stroke | 11/24 | 12/24 | | |
MIRACLE-S, NCT06688162: Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage--Small Hemorrhage Evacuation |
|
|
| Not yet recruiting | N/A | 750 | NA | Usual Care, Minimally Invasive Soft Channel Brain Haemorrhage Evacuation (scMIS) | Capital Medical University, Fudan University, Linyi People's Hospital | Intracerebral Hemorrhage | 11/26 | 12/26 | | |
MIRACLE-L, NCT06688201: Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation |
|
|
| Recruiting | N/A | 550 | RoW | Other neurosurgical techniques, Minimally Invasive Soft Channel Brain Haemorrhage Evacuation | Capital Medical University, Linyi People's Hospital, Fudan University | Intracerebral Hemorrhage | 11/26 | 12/26 | | |
RICA-2, NCT05982015: Efficacy Study II on Remote Ischemic Conditioning for the Prevention of Stroke-Associated Pneumonia |
|
|
| Completed | N/A | 1651 | RoW | Remote ischemic conditioning, Sham remote ischemic conditioning | Capital Medical University | Stroke | 09/24 | 12/24 | | |
| Not yet recruiting | N/A | 3000 | NA | | Capital Medical University, Beijing Municipal Science & Technology Commission | Cerebral Venous Sinus Thrombosis, Deep Cerebral Vein Thrombosis, Cortical Vein Thrombosis | 05/28 | 05/29 | | |
| Not yet recruiting | N/A | 1000 | RoW | | Capital Medical University | Intracranial Stenosis | 06/22 | 07/22 | | |
| Recruiting | N/A | 500 | RoW | Endovascular Treatment | Capital Medical University | Acute Ischemic Stroke | 12/22 | 06/23 | | |
| Yu, Ming |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 04/25 | | |
| Recruiting | 3 | 2100 | Europe, Canada, Japan, US, RoW | Rimegepant/BHV3000, Matching placebo | Pfizer | Pediatric Migraine | 01/29 | 01/29 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
NCT04264260: Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment |
|
|
| Recruiting | 2 | 80 | RoW | Colchicine Tablets | Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University | Hepatocellular Carcinoma Stage IIIB, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma; With Hepatocellular Carcinoma, Hepatocellular Carcinoma Stage IV | 07/25 | 07/25 | | |
NCT05774873: IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 128 | RoW | IBI334 D, IBI334 C, IBI334 A, IBI334 B, IBI334 F, IBI334 E | Innovent Biologics (Suzhou) Co. Ltd. | Solid Tumors | 10/25 | 06/26 | | |
NCT04104282: the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. |
|
|
| Recruiting | N/A | 240 | RoW | | Xijing Hospital | Non-alcoholic Fatty Liver Disease | 12/25 | 12/25 | | |
NCT05187416: Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer |
|
|
| Recruiting | N/A | 50 | RoW | two-dimensional shear wave elastography | Xijing Hospital | Pancreatic Neoplasms | 10/22 | 10/22 | | |
| Yan, Hua |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
| Not yet recruiting | 3 | 8862 | RoW | Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo | Wuhan Union Hospital, China | Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine | 03/28 | 08/28 | | |
NCT06458595: Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) |
|
|
| Recruiting | 1/2 | 44 | RoW | KH658 | Chengdu Origen Biotechnology Co., Ltd. | Age-related Macular Degeneration | 03/26 | 12/26 | | |
| Terminated | N/A | 51 | RoW | Spectral CT | Philips (China) Investment CO., LTD, Shanghai Changzheng Hospital, Ruijin Hospital, West China Hospital | CT Scanning | 11/22 | 02/23 | | |
NCT05396209: To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes. |
|
|
| Recruiting | N/A | 80 | RoW | Hydrated Amniotic Membrane Plug, ILM filling, Conventional ILM peeling | Oriental Neurosurgery Evidence-Based-Study Team | Macular Holes | 05/24 | 06/25 | | |
| Not yet recruiting | N/A | 500 | RoW | Assessment of plaque morphology, structure, and stability in non-culprit lesions | Chinese PLA General Hospital | Coronary Arterial Disease (CAD), Acute Coronary Syndromes | 12/27 | 12/31 | | |
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden |
|
|
| Recruiting | N/A | 3838 | RoW | Thrombus aspiration, PCI Alone | Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 08/25 | 02/26 | | |
| Wei, Ming |
| Recruiting | 3 | 452 | RoW | Remote ischemic conditioning, RIC, Sham remote ischemic conditioning, Sham RIC, Standard medication therapy | Capital Medical University | Intracerebral Hemorrhage, Acute Stroke | 12/22 | 06/23 | | |
NCT06113848: Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy |
|
|
| Recruiting | 3 | 80 | RoW | Intra-Arterial TNK and Albumin, Intra-Arterial TNK, Intra-Arterial Albumin, sham | Tianjin Huanhu Hospital | Acute Ischemic Stroke | 09/24 | 09/24 | | |
NCT06545734: Effectiveness and Biological Mechanism of Direct Ischemic Post-conditioning for Acute Stroke Patients Due to Large Vessel Occlusion |
|
|
| Recruiting | 2 | 60 | RoW | Direct Ischemic Post-conditioning, Endovascular therapy | Tianjin Huanhu Hospital | Stroke, Acute, Neuroprotection, Ischemic Conditioning | 09/24 | 09/24 | | |
| Recruiting | 1/2 | 20 | RoW | Mechanical thrombectomy combined with ischemic post-conditioning | Capital Medical University | Acute Ischemic Stroke, Reperfusion Injury | 12/23 | 03/24 | | |
NCT05953623: Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients |
|
|
| Not yet recruiting | 1 | 30 | RoW | Albumin | Tianjin Huanhu Hospital | Stroke, Acute Ischemic, Albumin, Endovascular Procedures, Large Vessel Occlusion | 02/24 | 02/24 | | |
| Recruiting | N/A | 1000 | RoW | Mechanical Thrombectomy, Ischemic post-conditioning, Selective Hypohermia | Tianjin Huanhu Hospital | Endovascular Thrombectomy, Large Vessel Occlusion, Acute Ischemic Stroke | 12/28 | 12/28 | | |
NCT06456437: Ischemic Post-conditioning in the Treatment of Acute Ischemic Stroke |
|
|
| Recruiting | N/A | 200 | RoW | Post-conditioning Balloon dilation and contraction | Ming Wei | Acute Ischemic Stroke, Large Vessel Occlusion, Intracranial Artery Occlusion With Cerebral Infarction, Endovascular Treatments | 09/25 | 12/25 | | |
NCT06213870: Screening of Endovascular Thrombectomy With MRI in Acute Ischemic Stroke |
|
|
| Completed | N/A | 309 | RoW | Surgical criteria | Tianjin Huanhu Hospital | Fluid-attenuated Inversion Recovery Sequence Vascular Hyperintensity-diffusion-weighted Imaging Mismatch(FVH-DWI Mismatch), Image Evaluation, Endovascular Thrombectomy | 08/23 | 11/23 | | |
NCT06260969: Endovascular Treatment of Acute Ischemic Stroke With Underlying Intracranial Artery Stenosis |
|
|
| Recruiting | N/A | 470 | RoW | balloon dilatation, endovascular stenting, aspiration catheter, stent retriever, Tirofiban, intracranial stenting, normal saline | Tianjin Huanhu Hospital | Large Vessel Occlusion, Intracranial Artery Occlusion With Cerebral Infarction, Endovascular Treatments, Acute Ischemic Stroke | 09/25 | 09/25 | | |
MIELS, NCT05735301: Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours |
|
|
| Recruiting | N/A | 352 | RoW | Endovascular, Drug, Drug conservative therapy | Tianjin Huanhu Hospital | Endovascular Thrombectomy | 09/24 | 09/24 | | |
NCT05404373: Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke |
|
|
| Completed | N/A | 100 | RoW | Normobaric Hyperoxia (NBO), Low flow oxygen | Capital Medical University, Tianjin Huanhu Hospital | Stroke, Acute, Neuroprotection, Endovascular Treatment | 09/23 | 09/23 | | |
NCT06654375: Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography |
|
|
| Recruiting | N/A | 350 | RoW | Endovascular Thrombectomy | Tianjin Huanhu Hospital | Stroke Acute, Thrombectomy, Medical Treatment, Large Vessel Occlusion | 12/27 | 12/27 | | |
| Recruiting | N/A | 5000 | RoW | Endovascular Therapy | Tianjin Huanhu Hospital | Stroke, Acute Ischemic, Endovascular Procedures, Large Vessel Occlusion | 12/28 | 12/28 | | |
NCT06094569: Medical Imaging Screening for Posterior-circulation Ischemic Stroke |
|
|
| Recruiting | N/A | 1000 | RoW | Endovascular Therapy | Tianjin Huanhu Hospital | Endovascular Thrombectomy | 12/29 | 12/29 | | |
NCT05653505: Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis |
|
|
| Not yet recruiting | N/A | 160 | RoW | Remote Ischemic Conditioning | Tianjin Huanhu Hospital | Intracranial Arteriosclerosis, Ischemic Preconditioning, Endovascular Procedures | 01/26 | 07/26 | | |
| Ji, Yong |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease |
|
|
| Recruiting | 2a | 60 | RoW | 50561 high dose, 50561 low dose, Placebo | Beijing Joekai Biotechnology LLC | Alzheimer's Disease | 05/24 | 06/24 | | |
| wu, jialing |
| Recruiting | 2 | 103 | RoW | Continuous, hyperfractionated, accelerated radiotherapy(CHART) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | De-escalated Radiotherapy; Head and Neck Cancer | 12/26 | 12/28 | | |
| Recruiting | 2 | 168 | RoW | Propranolol Hydrochloride, control group | Beijing Tiantan Hospital | Stroke, Vascular Accident, Intracranial Hemorrhages, Intracerebral Hemorrhage, Hemorrhagic Stroke, Stroke, Acute | 07/24 | 07/25 | | |
SOLUTION-2, NCT06374667: The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction |
|
|
| Recruiting | N/A | 134 | RoW | Y-3 ICO injection, Y-3 intravenous injection, Conventional treatment | yilong Wang | Stroke, Acute Ischemic, Blood-Brain Barrier | 03/26 | 03/27 | | |
